Literature DB >> 17921694

Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion?

Xiaoning Bi1, Guanghong Liao.   

Abstract

Increasing evidence shows that autophagy, particularly macroautophagy, plays a Dr. Jekyll and Mr. Hyde role in determining cell fate; autophagic activity can be protective under certain conditions, whereas it may lead to cell death under others. Niemann-Pick Type C (NPC) disease is an early onset autosomal recessive disorder characterized by accumulation of cholesterol and other lipids in late endosomes/lysosomes. About 95% of the cases are caused by mutations in the NPC1 gene, whereas the remaining 5% are due to mutations in the NPC2 gene. Severe neurodegeneration that accompanies NPC is likely the fatal cause in this disease, although the underlying mechanism remains unclear. Our study shows that autophagic activity is enhanced in Npc1-/- mice, as evidenced by increased levels of LC3-II and the number of autophagic vacuole-like structures. Interestingly, LC3 immunoreactivity co-localizes with filipin-labeled cholesterol clusters inside Purkinje cells. Furthermore, increases in autophagic activity are closely associated with alteration in lysosomal function and protein ubiquitination. In this article, these results are further discussed in the context of autophagic-lysosomal function and neuronal survival and degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921694     DOI: 10.4161/auto.5074

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  25 in total

Review 1.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

2.  Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation.

Authors:  Hanna Appelqvist; Cathrine Nilsson; Brett Garner; Andrew J Brown; Katarina Kågedal; Karin Ollinger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 4.  Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease.

Authors:  Nabab Khan; Norman J Haughey; Avindra Nath; Jonathan D Geiger
Journal:  Brain Res       Date:  2019-08-16       Impact factor: 3.252

5.  Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

6.  Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Authors:  Xuesong Chen; Liang Hui; Mahmoud L Soliman; Jonathan D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014

7.  Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Austin J Pharmacol Ther       Date:  2014-08-26

Review 8.  Cholesterol in Niemann-Pick Type C disease.

Authors:  Xiaoning Bi; Guanghong Liao
Journal:  Subcell Biochem       Date:  2010

9.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

10.  Neuronal loss of Drosophila NPC1a causes cholesterol aggregation and age-progressive neurodegeneration.

Authors:  Scott E Phillips; E A Woodruff; Ping Liang; Meaghan Patten; Kendal Broadie
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.